Dr. David Spigel: What are the most promising targeted therapy approaches in lung cancer for the next few years?
Feb 23, 2013 ·
3m 50s
Dr. David Spigel, Sarah Cannon Cancer Center, offers his perspective on the agents he feels most likely to become clinical tools against lung cancer over the next few years.
Information
| Author | cancerGRACE |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
